These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4007415

  • 1. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
    Yokosuka O, Omata M, Imazeki F, Hirota K, Mori J, Uchiumi K, Ito Y, Okuda K.
    Gastroenterology; 1985 Aug; 89(2):246-51. PubMed ID: 4007415
    [Abstract] [Full Text] [Related]

  • 2. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M, Uchiumi K.
    J Hepatol; 1986 Aug; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [Abstract] [Full Text] [Related]

  • 3. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 4. Short-term prednisolone followed by recombinant human alpha-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. A prospective and randomized trial.
    Brissot P, Jacquelinet C, Jouanolle H, David V, Guyader D, Guéguen M, Blayau M, Lescoat G, Messner M, Deugnier Y.
    J Hepatol; 1991 Mar; 12(2):181-9. PubMed ID: 2050997
    [Abstract] [Full Text] [Related]

  • 5. Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.
    Takano S, Omata M, Yokosuka O, Imazeki F, Ohto M.
    Dig Dis Sci; 1992 Nov; 37(11):1633-43. PubMed ID: 1425062
    [Abstract] [Full Text] [Related]

  • 6. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
    Scullard GH, Andres LL, Greenberg HB, Smith JL, Sawhney VK, Neal EA, Mahal AS, Popper H, Merigan TC, Robinson WS, Gregory PB.
    Hepatology; 1981 Nov; 1(3):228-32. PubMed ID: 6169615
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
    Hoofnagle JH, Davis GL, Hanson RG, Pappas SC, Peters MG, Avigan MI, Waggoner JG, Howard R, Jones EA, Straus SE.
    J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
    Weller IV, Bassendine MF, Craxi A, Fowler MJ, Monjardino J, Thomas HC, Sherlock S.
    Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
    [Abstract] [Full Text] [Related]

  • 9. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
    Lee SU, Choi KH, Ha BJ, Suh SY, Han BH, Ku JY, Park BC.
    Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
    Liaw YF, Lin DY, Chen TJ, Chu CM, Sheen IS.
    Infection; 1984 Jan; 12(4):248-50. PubMed ID: 6490167
    [Abstract] [Full Text] [Related]

  • 11. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA.
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [Abstract] [Full Text] [Related]

  • 12. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
    Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC.
    J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A, Weller IV, Bassendine MF, Fowler MJ, Monjardino J, Thomas HC, Sherlock S.
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [Abstract] [Full Text] [Related]

  • 19. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
    Marcellin P, Pouteau M, Loriot MA, Boyer N, Degos F, Calès P, Bettan L, Bacq Y, Coppére H, Grange JD.
    Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.